Is Vitamin K Bone Density Randomized Trial safe?

Quick Answer

Vitamin K Bone Density Randomized Trial has evidence relevant to safety, limits, and clinician-discussion contexts, but conclusions should stay close to the cited sources. One representative finding is: 1 2 3 4 5 6 7 8 Bone health is a major concern for postmenopausal women, as estrogen deficiency after menopause accelerates bone resorption and suppresses bone formation, leading to reduced bone mineral density (BMD) and an increased risk of fractures [].

Key Takeaways

011 2 3 4 5 6 7 8 Bone health is a major concern for postmenopausal women, as estrogen deficiency after menopause accelerates bone resorption and suppresses bone formation, leading to reduced bone mineral density (BMD) and an increased risk of fractures []. [Jung Susie (2026)]
02Among the various risk factors for osteoporosis, modifiable lifestyle factors—particularly insufficient calcium and vitamin D intake, as well as inadequate physical activity—are of special importance, alongside other established factors such as advanced age and low body mass index (BMI) []. [Jung Susie (2026)]
03In Korea, calcium and vitamin D intakes remain persistently inadequate, largely due to low dairy consumption associated with traditional dietary patterns and widespread lactose intolerance, and this insufficiency becomes increasingly pronounced with advancing age [,]. [Jung Susie (2026)]
04Given these physiological vulnerabilities, osteoporosis has emerged as a significant global public health issue, particularly among postmenopausal women, due to its strong association with fractures, morbidity, mortality, and substantial socioeconomic burden [,]. [Jung Susie (2026)]

The current Migaku evidence database contains 2 reusable source documents for Vitamin K Bone Density Randomized Trial. This answer focuses on safety, limits, and clinician-discussion contexts. - 1 2 3 4 5 6 7 8 Bone health is a major concern for postmenopausal women, as estrogen deficiency after menopause accelerates bone resorption and suppresses bone formation, leading to reduced bone mineral density (BMD) and an increased risk of fractures []. [Jung Susie (2026); evidence level 2] - Among the various risk factors for osteoporosis, modifiable lifestyle factors—particularly insufficient calcium and vitamin D intake, as well as inadequate physical activity—are of special importance, alongside other established factors such as advanced age and low body mass index (BMI) []. [Jung Susie (2026); evidence level 2] - In Korea, calcium and vitamin D intakes remain persistently inadequate, largely due to low dairy consumption associated with traditional dietary patterns and widespread lactose intolerance, and this insufficiency becomes increasingly pronounced with advancing age [,]. [Jung Susie (2026); evidence level 2] - Given these physiological vulnerabilities, osteoporosis has emerged as a significant global public health issue, particularly among postmenopausal women, due to its strong association with fractures, morbidity, mortality, and substantial socioeconomic burden [,]. [Jung Susie (2026); evidence level 2] - Accordingly, contemporary guidelines no longer recommend IN-CAL as first-line treatment for chronic osteoporosis, and concerns regarding a potential malignancy signal further limited long-term use. [Ahmad Areeb (2026); evidence level 3] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.

Sources